Skip to content
Screener

AdaptHealth AHCO Q3 2025 earnings

Reported November 4, 2025 · Before market open

Revenue$820.3MMiss by $12.2M
EPS$0.22Miss by $0.02
Revenue estimate$832.5M
EPS estimate$0.24

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$725.9M
EPS estimate-$0.05

Financials

Q3 2025

Income statement

See full
Revenue$820.3M+1.8%
Gross profit$161.9M-0.1%
Operating income$61.7M-2.8%
Net income$24.5M+7.2%
EPS (diluted)$0.16+6.7%

Balance sheet

See full
Cash & equivalents$80.4M-19.8%
Total debt$1.9B-12.6%
Total equity$1.6B+6.6%
Total assets$4.4B-1.9%

Cash flow

See full
Operating cash flow$161.1M+11.5%
CapEx$94.2M+58.2%
Free cash flow$66.8M-21.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.21B-19.1%
Enterprise value$3.03B-15.1%
P/E14.7×—
P/S0.4×-0.1×

Profitability

See full
Gross margin19.3%-5.0pp
Operating margin8%+6.9pp
Net margin2.5%+1.5pp
FCF margin6.5%-0.5pp

Returns & leverage

See full
Return on equity5.2%+3.1pp
Debt / equity1.2×-0.3×
Current ratio1.1×-0.2×

Segments

By segment

See full
Sleep Health$354.8M+5.7%
Respiratory Health$177.0M+7.8%
Diabetes Health$150.1M+6.4%
Wellness at Home$138.4M-16.0%

FAQ

When did AdaptHealth report Q3 2025 earnings?
AdaptHealth (AHCO) reported Q3 2025 earnings on November 4, 2025 before market open.
What were AdaptHealth's Q3 2025 revenue and EPS?
AdaptHealth reported revenue of $820.3M and eps of $0.22 for Q3 2025.
Did AdaptHealth beat estimates in Q3 2025?
Revenue missed the consensus estimate of $832.5M by $12.2M. EPS missed the consensus estimate of $0.24 by $0.02.
How did AdaptHealth's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.8% from $805.9M a year earlier and eps grew 46.7% from $0.15.
Where can I find AdaptHealth's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-048527) and the 10-Q periodic report (0001628280-25-048944) directly on SEC EDGAR. The filing index links above go to sec.gov.